DE2351948A1 - 4-aryl-5-aminoalkyl-4-oxazolin-2-one, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen - Google Patents

4-aryl-5-aminoalkyl-4-oxazolin-2-one, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen

Info

Publication number
DE2351948A1
DE2351948A1 DE19732351948 DE2351948A DE2351948A1 DE 2351948 A1 DE2351948 A1 DE 2351948A1 DE 19732351948 DE19732351948 DE 19732351948 DE 2351948 A DE2351948 A DE 2351948A DE 2351948 A1 DE2351948 A1 DE 2351948A1
Authority
DE
Germany
Prior art keywords
group
fluorophenyl
oxazolin
pharmaceutically acceptable
acceptable salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19732351948
Other languages
German (de)
English (en)
Inventor
Giuseppe Dr Cascio
Elso Dr Manghisi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Luso Farmaco dItalia SpA
Original Assignee
Istituto Luso Farmaco dItalia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2811573A external-priority patent/IT1056733B/it
Application filed by Istituto Luso Farmaco dItalia SpA filed Critical Istituto Luso Farmaco dItalia SpA
Publication of DE2351948A1 publication Critical patent/DE2351948A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36One oxygen atom
    • C07D263/38One oxygen atom attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/46Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19732351948 1972-10-16 1973-10-16 4-aryl-5-aminoalkyl-4-oxazolin-2-one, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen Withdrawn DE2351948A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT3053672 1972-10-16
IT2811573A IT1056733B (it) 1973-08-22 1973-08-22 4 aril 5 aminoalohil 4 ossazolin 2 oni loro derivati e processi per la loro preparazione

Publications (1)

Publication Number Publication Date
DE2351948A1 true DE2351948A1 (de) 1974-04-25

Family

ID=26328766

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732351948 Withdrawn DE2351948A1 (de) 1972-10-16 1973-10-16 4-aryl-5-aminoalkyl-4-oxazolin-2-one, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen

Country Status (13)

Country Link
US (1) US3930008A (US07655688-20100202-C00109.png)
JP (1) JPS4993360A (US07655688-20100202-C00109.png)
CA (1) CA1016550A (US07655688-20100202-C00109.png)
CH (1) CH605859A5 (US07655688-20100202-C00109.png)
DE (1) DE2351948A1 (US07655688-20100202-C00109.png)
DK (1) DK135122B (US07655688-20100202-C00109.png)
ES (1) ES419632A1 (US07655688-20100202-C00109.png)
FI (1) FI57752C (US07655688-20100202-C00109.png)
FR (1) FR2202701B1 (US07655688-20100202-C00109.png)
GB (1) GB1429571A (US07655688-20100202-C00109.png)
NL (1) NL161154C (US07655688-20100202-C00109.png)
NO (1) NO140299C (US07655688-20100202-C00109.png)
SE (1) SE391717B (US07655688-20100202-C00109.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0180136A2 (de) 1984-11-02 1986-05-07 Bayer Ag Substituierte Azolylmethyl-cyclopropyl-carbinol-Derivate
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123529A (en) * 1976-04-23 1978-10-31 Lilly Industries Limited Phenylpiperazine derivatives
PT77428B (fr) * 1982-10-05 1986-02-27 Cortial Procede pour preparer de nouvelles amino-2-substitue-5-oxazoli-nes-2 et des compositions les contenant
FR2546167B2 (fr) * 1983-05-19 1985-07-12 Cortial Nouvelles amino-2 piperazino et piperidinomethyl-5 oxazolines-2, leur methode de preparation ainsi que leur application therapeutique
US6159990A (en) * 1997-06-18 2000-12-12 Synaptic Pharmaceutical Corporation Oxazolidinones as α1A receptor antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3576808A (en) * 1967-09-15 1971-04-27 Miles Lab N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones
JPS4922770A (US07655688-20100202-C00109.png) * 1972-06-22 1974-02-28

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0180136A2 (de) 1984-11-02 1986-05-07 Bayer Ag Substituierte Azolylmethyl-cyclopropyl-carbinol-Derivate
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones

Also Published As

Publication number Publication date
NL161154C (nl) 1980-01-15
NL7314147A (US07655688-20100202-C00109.png) 1974-04-18
AU6121673A (en) 1975-04-10
ES419632A1 (es) 1976-06-16
CA1016550A (en) 1977-08-30
FR2202701B1 (US07655688-20100202-C00109.png) 1980-01-11
US3930008A (en) 1975-12-30
DK135122C (US07655688-20100202-C00109.png) 1977-08-08
NL161154B (nl) 1979-08-15
SE391717B (sv) 1977-02-28
FR2202701A1 (US07655688-20100202-C00109.png) 1974-05-10
FI57752B (fi) 1980-06-30
FI57752C (fi) 1980-10-10
DK135122B (da) 1977-03-07
CH605859A5 (US07655688-20100202-C00109.png) 1978-10-13
NO140299C (no) 1979-08-08
NO140299B (no) 1979-04-30
GB1429571A (en) 1976-03-24
JPS4993360A (US07655688-20100202-C00109.png) 1974-09-05

Similar Documents

Publication Publication Date Title
CH399465A (de) Verfahren zur Herstellung von Indolyloverbindungen
EP0005828B1 (de) Neue substituierte Phenylpiperazinderivate, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
EP0738722A1 (de) 5-Amino-benzofuran-2-carbonsäurederivate
US2846437A (en) Lower alkyl 4-phenyl-1-(substituted-alkyl) piperidine-4-carboxylates and preparationthereof
EP0264081B1 (de) Oxadiazolylalkylpurin-Derivate, ihre Herstellung und ihre Verwendung in pharmazeutischen Mitteln
EP0000220B1 (de) Dihydrouracile, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2651083C2 (US07655688-20100202-C00109.png)
DE1670772C3 (de) 4H-3,1-Benzoxazin-Derivate, deren Salze und pharmazeutische Präparate
DE2628189A1 (de) 3-phenylindoline, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2351948A1 (de) 4-aryl-5-aminoalkyl-4-oxazolin-2-one, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DD235256A5 (de) Verfahren zur herstellung neuer substituierter pyrrolidinone
DE1954584A1 (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
DE1620449A1 (de) Substituierte Benzimidazole
DE2824677A1 (de) Neue substituierte phenylpiperazinderivate und verfahren zu deren herstellung
EP0018360B1 (de) N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung
CH638216A5 (de) Oxadiazolopyrimidin-deriate.
DE2560104C2 (de) Verfahren zur Herstellung von in 2-und 6-Stellung des Phenylkerns substituierten 1-Benzoyl-2-phenylamino-2-imidazolinderivaten
EP0007525A1 (de) 2-(4-Aminopiperidino)-3,4-dihydrochinoline, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung
CH638215A5 (de) Oxadiazolopyrimidin-derivate.
DD141157A1 (de) Verfahren zur herstellung von neuen arylaminoimidazolinderivaten
DE2313256A1 (de) 1,2-benzisoxazolderivate, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0062844B1 (de) Substituierte Benzo(de)isochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CH639656A5 (de) Stickstoffhaltige heterocyclische verbindungen und verfahren zu deren herstellung.
DE2530792A1 (de) 1,2,4-benzothia(iv)diazin-derivate
DE2610864A1 (de) Carbamate von 2-halogenergolinen und 2-halogenergolenen und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee